1) inhibitors of inflammatory mediators
炎症介质阻滞剂
1.
In this paper, the research progress of drugs for treatment and prevention of COPD, including bronchodilators, glucocorticoids, phosphodiesterase type 4 inhibitors,inhibitors of inflammatory mediators,protease inhibitors and mucoregulators are reviewed.
现对其防治药物,如支气管扩张剂、糖皮质激素、磷酸二酯酶4(PDE4)抑制剂、炎症介质阻滞剂、蛋白酶抑制剂、黏液调整剂等研究进展做一综述。
2) inflammatory mediator blocker
炎性介质阻断剂
1.
Effects of inflammatory mediator blocker on neurological deficits,apoptosis and expression of caspase-3 following cerebral ischemia-reperfusion in rats
炎性介质阻断剂对大鼠脑缺血再灌注损伤后神经功能缺损、细胞凋亡及半胱氨酸蛋白酶-3表达的影响
3) Inflammatory Mediator
炎症介质
1.
Effects of Zhizi Jinhua decoction (栀子金花汤) on inflammatory mediators in rats with abdominal sepsis;
栀子金花汤对腹腔感染脓毒症大鼠炎症介质的影响
2.
Experimental study on the influence of spleen on the release of inflammatory mediator in rats with acute pancreatitis;
脾脏在大鼠急性胰腺炎炎症介质释放中的作用
3.
The effect of blood purification on removing plasma inflammatory mediators in HFRS patients;
血液净化对肾综合征出血热炎症介质的清除作用
4) inflammatory mediators
炎症介质
1.
Regulation of the hypoxia inducible factor-1α by the inflammatory mediators;
炎症介质对HIF-1的表达调控
2.
Effects of Injectio Radix Astragali on inflammatory mediators in essential hypertension;
黄芪注射液对高血压病患者炎症介质的影响
3.
Effect of treatment with Xuebijing injection (血必净注射液) on serum inflammatory mediators and Th1/2 of spleen in rats with sepsis;
血必净注射液对脓毒症大鼠血清炎症介质及Th1/2的影响
5) mediators of inflammation
炎症介质
1.
The level of mediators of inflammation,the granuloma mass caused by st.
为观察腰腿痛胶囊对化学性神经根炎模型大鼠的抗炎镇痛作用,复制大鼠化学性神经根炎模型,模拟腰椎间盘突出症,分别在造模后3、7、14、21天检测刺激物所致肉芽肿质量、神经根周围组织中炎症介质(前列腺素E2和5-羟色胺)水平并进行神经根组织学观察。
2.
Objective To investigate the effect of mediators of inflammation on the peripheral blood levels of HMGB-1、TNF-α、IL-6 and the mechanism of action of HMGB-1 in patients with systemic inflammatory response syndrome or sepsis;meanwhile to observe the benefit of clinical symptom and prognosis of petients with systemic inflammatory response syndrome or sepsis.
目的探讨连续性静-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)技术对全身性炎症反应综合症(systemic inflammatory responsesyndrome,SIRS)/脓毒症(sepsis)患者外周血高迁移率族蛋白-1(high mobilitygroup box chromosomal protein 1,HMGB-1)、肿瘤坏死因子-α(tumor necrosisfactor-α,TNF-α)、白细胞介素-6(interleukin-6,IL-6)等炎症介质水平的影响,同时观察CVVH对患者临床症状及预后的影响。
6) Inflammation mediators
炎症介质
1.
Inflammation mediators mediated by TLR4 are molecular basis of inflammation in acute lung inury.
Toll样受体4(TLR4)基因多态性与急性肺损伤原发病因免疫应答的启动及炎症反应程度有关,TLR4所介导生成的炎症介质是急性肺损伤炎症反应的分子基础。
2.
Objective To evaluate the effect of selected decontamination of the digestive tract(SDD) on intestine-derived endotoxmia,inflammation mediators and clinical outcome in patients with rheumatic heart disease undergoing valve replacement under cardiopulmonary bypass(CPB).
目的探讨术前选择性消化道去污染(SDD)对体外循环(CPB)心内直视术患者肠源性内毒素血症、炎症介质和临床结果的影响。
3.
Recent epidemical study indicates that the incidence of AD in some populations is substantially influenced by the gene polymorphisms of the inflammation mediators.
近来流行病学研究显示炎症介质的基因多态性可以影响阿尔茨海默病在人群中的发病率。
补充资料：炎症介质
炎症介质
inflammatory mediator
又称“化学介质”。参与炎症反应的化学活性物质。在炎症渗出性反应中，能扩张血管和增高血管壁通透性，具有促成炎症血管反应的重要作用。内源性炎症介质、来源于组织或血浆。主要有血管活性胺，如组胺和5-羟色胺、激肽类，补体系统C3、C5、C567、前列腺素，以及中性粒细胞释放的炎症介质，如阳离子蛋白质、酸性蛋白酶、中性蛋白酶和多种淋巴因子等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条